Monoclonal B cells detected in autologous PBSC grafts from patients with classical Hodgkin lymphoma: impact on relapse and survival following transplantation
暂无分享,去创建一个
H. Atkins | D. Allan | L. Huebsch | S. Mcdiarmid | A. Giulivi | M. Sabloff | I. Bence-Bruckler | L. Yang | M. Halpenny | S. Takach | J. Ho | E. Sabri | L. Martín | Lin Yang | L. Martin | L. Martin | H. Atkins | David S. Allan | Antonio Giulivi
[1] M. Siedner,et al. Circulating clonotypic B cells in classic Hodgkin lymphoma. , 2009, Blood.
[2] S. le Cessie,et al. Long‐term follow‐up of a population based cohort with monoclonal proteinaemia , 2009, British journal of haematology.
[3] T. Usa,et al. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders , 2008, Journal of endocrinological investigation.
[4] Y. Oki,et al. Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma , 2008, Cancer.
[5] J. Olsen,et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. , 2006, Journal of the National Cancer Institute.
[6] G. M. Taylor,et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. , 2005, Blood.
[7] P. Mclaughlin,et al. A pilot study of rituximab in patients with recurrent, classic Hodgkin disease , 2003, Cancer.
[8] T. McDonnell,et al. BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens. , 2002, Blood.
[9] R. Moog,et al. Concurrent collection of in-line filtered platelets and red blood cells by apheresis , 2002, Annals of Hematology.
[10] A. Marx,et al. Autoimmune lymphoproliferative syndrome associated with severe humoral immunodeficiency and monoclonal gammopathy , 2002, Annals of Hematology.
[11] G. Bonadonna,et al. CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] Terry M Therneau,et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. , 2002, The New England journal of medicine.
[13] T. McDonnell,et al. BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] M. Kvarnström,et al. Myelin protein P0‐specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS) , 2002, Clinical and experimental immunology.
[15] A. López-Guillermo,et al. Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Armitage,et al. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR) , 2001, Bone Marrow Transplantation.
[17] H. Stein,et al. Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. , 2000, Blood.
[18] J. Armitage,et al. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. , 1998, The New England journal of medicine.
[19] V. Diehl,et al. Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's disease. , 1998, Blood.
[20] A. Goldstone,et al. High-dose therapy and autologous stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT , 1997, Bone Marrow Transplantation.
[21] R. Bouabdallah,et al. Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from the French registry , 1997, Bone Marrow Transplantation.
[22] S. Horning,et al. High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices. , 1997, Blood.
[23] C. von Kalle,et al. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. , 1996, Blood.
[24] S. Pileri,et al. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. , 1995, The New England journal of medicine.
[25] R Fischer,et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[26] C. Vnencak-Jones,et al. Determination of B-cell clonality in paraffin-embedded endoscopic biopsy specimens of abnormal lymphocytic infiltrates and gastrointestinal lymphoma by polymerase chain reaction. , 1994, American journal of clinical pathology.
[27] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[28] W. Chan,et al. Detection and Relevance of Minimal Disease in Lymphomas , 2004, Cancer and Metastasis Reviews.
[29] M. Andreeff,et al. Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease , 2002, Cancer.